DarioHealth announces agreement with DexCom
DarioHealth (NASDAQ:DRIO) has announced an agreement with Dexcom (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring technology, to integrate its market-leading CGMs, into Dario's multi-chronic condition platform.
This agreement enables the integration of data from Dexcom CGMs directly into Dario's metabolic solution, making it easy for people using the wearable device to benefit from Dario's highly personalized support.

The integration with Dexcom builds on the collaboration between Dario and Sanofi US which aims to establish an ecosystem of dedicated technology partners and industry-leading digital therapeutics solutions.
"We're proud of our ongoing collaboration with Sanofi US which is helping Dario to establish new innovations to meet the needs of our customers and members as demonstrated by this Dexcom integration," said Rick Anderson, President of Dario.